Skip to main content
Cipla Ltd. logo

Cipla Ltd. — Investor Relations & Filings

Ticker · CIPLA ISIN · INE059A01026 LEI · 335800KMJJYEDDK82Q34 BSE.NS Manufacturing
Open in API
Filings indexed 2,616 across all filing types
Latest filing 2019-09-13 Regulatory Filings
Country IN India
Listing BSE.NS CIPLA

About Cipla Ltd.

https://www.cipla.com/

Cipla Ltd. is a global pharmaceutical company focused on the development, manufacturing, and marketing of a wide range of generic and branded medicines. The company maintains a diverse portfolio of over 1,500 products across various therapeutic areas, including respiratory, anti-retroviral, urology, cardiology, anti-infective, and central nervous system treatments. It is recognized for its leadership in respiratory care and its historical role in making HIV/AIDS treatment affordable through the introduction of low-cost antiretroviral drugs. Operating with a strong emphasis on research and development, the firm utilizes advanced technology to produce complex generics and drug delivery systems. Its global footprint spans multiple continents, serving healthcare providers and patients in numerous international markets through a robust supply chain and manufacturing infrastructure.

Recent filings

Filing Released Lang Actions
Please find enclosed the schedule of analyst and institutional investor meetings of the Company.
Regulatory Filings Classification · 90% confidence The document contains a brief table listing dates, fund/investor names, venues, and types of meetings. There is no detailed financial data, no report content, no regulatory language, and no mention of report publication or voting results. The document is very short (272 characters) and appears to be a simple meeting schedule or attendance record. It does not fit into categories like Annual Report, Earnings Release, or any detailed financial or governance report. Given the lack of specific report content or announcements, and the nature of the content, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous filings that do not fit elsewhere.
2019-09-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 60% confidence The document contains a table listing dates, fund/investor names, venues, and types of meetings, such as in-person and call meetings. There is no detailed financial data, no report content, no regulatory or legal information, and no announcements of voting results or management changes. The document appears to be a schedule or summary of investor meetings or presentations. Given the nature of the content, it best fits the category of Investor Presentation (IP), which includes detailed presentations for investors focusing on financials, strategy, and market position. Although the document is short and lacks detailed financials, it lists investor meetings which are typically part of investor presentations or related materials. Therefore, the classification is IP with moderate confidence due to limited content.
2019-09-03 English
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, attached herewith is the schedule of Analysts / Institutional Investor Meetings.
Regulatory Filings Classification · 90% confidence The document contains a table listing dates, fund/investor names, venues, and types of meetings, such as 'Inperson' and 'Call'. There is no detailed financial data, no report content, no regulatory references, or any indication of a formal report or announcement. The document is very short (410 characters) and appears to be a schedule or summary of meetings rather than a formal filing. It does not fit into categories like Annual Report, Earnings Release, or any detailed report. It is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2019-09-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 80% confidence The document is very short (380 characters) and contains a table listing dates, fund/investor names, venues, and types of meetings. There is no detailed financial data, no report content, no regulatory language, or any indication of a formal report or announcement. It appears to be a schedule or summary of investor meetings or calls. Given the nature of the content, it does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is not a transcript or presentation either. The closest relevant category is Investor Presentation (IP), as it relates to meetings with investors, but since this is just a schedule and not a presentation document, it is more appropriate to classify it as Regulatory Filings (RNS) as a fallback for miscellaneous filings that do not fit other categories.
2019-08-26 English
Please find enclosed the schedule of analyst / institutional investor meetings.
Investor Presentation Classification · 60% confidence The document is very short (380 characters) and contains a table listing dates, fund/investor names, venues, and types of meetings. There is no detailed financial data, no report content, no regulatory language, or any indication of a formal report or announcement. It appears to be a schedule or summary of investor meetings or calls. Given the lack of financial statements or detailed report content, and the nature of the content being a list of meetings, this does not fit into categories like Annual Report, Earnings Release, or Call Transcript. It is not a report publication announcement either, as it does not mention any report release. The best fitting category is Investor Presentation (IP), as such meeting schedules are often part of investor presentation materials or related documents. Confidence is moderate due to limited content but the context suggests investor-related meetings.
2019-08-26 English
Please find enclosed the schedule of analyst / institutional investor meetings of the Company
Investor Presentation Classification · 70% confidence The document consists of a brief tabular listing of investor meetings with dates, venues, and types of meetings. It does not contain financial statements, detailed financial analysis, or regulatory disclosures. The content is a schedule or summary of investor interactions rather than a formal report or announcement. Given the short length (542 characters) and the nature of the content, it is not an Annual Report, Earnings Release, or any detailed financial filing. It is best classified as an Investor Presentation (IP) since it relates to investor meetings and presentations, although it is quite brief. Confidence is moderate due to limited content but the context fits best with Investor Presentation.
2019-08-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.